
Naltisam Pharmaceutical Private Limited
About Naltisam Pharmaceutical Private Limited
Data last updated:
Naltisam Pharmaceutical Private Limited is a private limited company based in Delhi, India. It operates in the crop protection segment of the agriculture sector. It was incorporated on 27 May 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2021PTC381538. Its GSTIN is 23AABCZ7477N1ZM (Madhya Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Meera Kumari and Chouhan Niraj Kant Singh.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 52 G.F. Street No – 7 West Guru Angad Nagar Laxmi Nagar, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹18.47 Lakh, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹23,680 (net margin 1.3%) and EBITDA of ₹32,012 (EBITDA margin 1.7%). Revenue has grown at a compounded annual rate (CAGR) of 39% over three years.
Company details
Contact details
Naltisam Pharmaceutical Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressB – 52 G.F. Street No – 7 West Guru Angad Nagar Laxmi Nagar, Delhi, India – 110092
- IndustryAgriculture, Crop Protection
To see the full contact details of Naltisam Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Naltisam Pharmaceutical is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 47 | Retail trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Naltisam Pharmaceutical Private Limited, buy the company report.
Financials of Naltisam Pharmaceutical Private Limited
FY 2025 filings availableNaltisam Pharmaceutical Private Limited reported revenue of ₹18.47 Lakh (up 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 39% over three years, including 8% growth in the latest year. EBITDA rose 126% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹32,012 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹23,680 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 1.7% | |||
| Net Profit Margin | 1.3% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Naltisam Pharmaceutical Private Limited, buy the company report.
Board of directors of Naltisam Pharmaceutical Private Limited
Naltisam Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Meera Kumari | Director | 27 May 2021 | 5 Years 5 Months | Current |
| Chouhan Niraj Kant Singh | Director | 27 May 2021 | 5 Years 5 Months | Current |
Legal cases
No court or tribunal cases involving Naltisam Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Naltisam Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Naltisam Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AABCZ7477N1ZM | Madhya Pradesh | Active | 13 Sep 2021 |
To see the full GST registrations and return filing status of Naltisam Pharmaceutical Private Limited, buy the company report.
Recent activity
Naltisam Pharmaceutical Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Chouhan Niraj Kant Singh was appointed as Director on 27 May 2021.
Frequently asked questions
Naltisam Pharmaceutical is an active private limited company based in Delhi, India. The company works in crop protection, within the agriculture industry. It was incorporated on 27 May 2021 (5+ years old) and is registered under CIN U51909DL2021PTC381538.
Naltisam Pharmaceutical has 2 current directors:
- Meera Kumari - Director
- Chouhan Niraj Kant Singh - Director
The latest financial statements of Naltisam Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Naltisam Pharmaceutical is 23AABCZ7477N1ZM, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Naltisam Pharmaceutical is U51909DL2021PTC381538. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Naltisam Pharmaceutical was incorporated on 27 May 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
Chouhan Niraj Kant Singh was appointed as Director on 27 May 2021. Meera Kumari was appointed as Director on 27 May 2021.
The registered office of Naltisam Pharmaceutical is at B – 52 G.F. Street No – 7 West Guru Angad Nagar Laxmi Nagar, Delhi, India – 110092.
Naltisam Pharmaceutical operates in the agriculture industry, in the crop protection segment.
Naltisam Pharmaceutical can be reached at its registered office: B – 52 G.F. Street No – 7 West Guru Angad Nagar Laxmi Nagar, Delhi, India – 110092.

